Related Experiment Video
Updated: Mar 8, 2026
Isolated Pancreatic Islet Treatment and Apoptosis Measurement
Published on: May 2, 2025
Construction and validation of the APOCHIP, a spotted oligo-microarray for the study of beta-cell apoptosis
Nils E Magnusson1, Alessandra K Cardozo, Mogens Kruhøffer
1Department of Clinical Biochemistry, Aarhus University Hospital, Denmark. nm@ki.au.dk
Background:
Type 1 diabetes mellitus (T1DM) is a autoimmune disease caused by a long-term negative balance between immune-mediated beta-cell damage and beta-cell repair/regeneration. Following immune-mediated damage the beta-cell fate depends on several genes up- or down-regulated in parallel and/or sequentially. Based on the information obtained by the analysis of several microarray experiments of beta-cells exposed to pro-apoptotic conditions (e.g. double stranded RNA (dsRNA) and cytokines), we have developed a spotted rat oligonucleotide microarray, the APOCHIP, containing 60-mer probes for 574 genes selected for the study of beta-cell apoptosis.
Results:
The APOCHIP was validated by a combination of approaches. First we performed an internal validation of the spotted probes based on a weighted linear regression model using dilution series experiments. Second we profiled expression measurements in ten dissimilar rat RNA samples for 515 genes that were represented on both the spotted oligonucleotide collection and on the in situ-synthesized 25-mer arrays (Affymetrix GeneChips). Internal validation showed that most of the spotted probes displayed a pattern of reaction close to that predicted by the model. By using simple rules for comparison of data between platforms we found strong correlations (rmedian= 0.84) between relative gene expression measurements made with spotted probes and in situ-synthesized 25-mer probe sets.
Conclusion:
In conclusion our data suggest that there is a high reproducibility of the APOCHIP in terms of technical replication and that relative gene expression measurements obtained with the APOCHIP compare well to the Affymetrix GeneChip. The APOCHIP is available to the scientific community and is a useful tool to study the molecular mechanisms regulating beta-cell apoptosis.
Insights
Researchers developed the APOCHIP, a novel microarray for studying beta-cell apoptosis in Type 1 diabetes. This tool demonstrates high reproducibility and accuracy, comparing well with existing gene expression platforms.
Area of Science:
- Molecular Biology
- Genomics
- Immunology
Background:
- Type 1 diabetes mellitus (T1DM) involves an imbalance between beta-cell damage and repair.
- Beta-cell fate after immune damage is influenced by gene regulation.
- Previous microarray analyses informed the development of a targeted gene set.
Purpose of the Study:
- To develop and validate a specialized microarray (APOCHIP) for studying beta-cell apoptosis.
- To assess the reliability and comparability of the APOCHIP for gene expression analysis.
Main Methods:
- Designed a spotted rat oligonucleotide microarray (APOCHIP) with 574 probes for beta-cell apoptosis-related genes.
- Validated the APOCHIP using dilution series and comparative analysis with Affymetrix GeneChips.
- Assessed probe performance and gene expression measurement correlations between platforms.
Main Results:
- Internal validation confirmed the reliability of most spotted probes.
- Strong correlations (median r=0.84) were observed between APOCHIP and Affymetrix GeneChip measurements.
- The APOCHIP demonstrated high reproducibility in technical replication.
Conclusions:
- The APOCHIP is a reproducible and accurate tool for gene expression analysis in beta-cell apoptosis research.
- APOCHIP data correlate well with established microarray platforms like Affymetrix GeneChips.
- The APOCHIP is available to researchers studying the molecular mechanisms of beta-cell apoptosis.
